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Abstract 
Background: Quality and effectiveness of care can be enhanced through the use of condition-
specific measures of satisfaction with treatment. The aim of the present study was to design and 
develop a measure of satisfaction with treatment for chronic kidney failure (CKF) for use in 
routine clinical care and clinical trials. The Renal Treatment Satisfaction Questionnaire (RTSQ) 
was designed to be suitable for people using any of the various treatment modalities for CKF. 
Items measure satisfaction with aspects of treatment including convenience, flexibility, freedom, 
and satisfaction to continue with present form of treatment.   
Methods: A 12-item RTSQ was investigated at a UK hospital-based renal unit, using data from 
140 outpatients undergoing renal replacement therapy (Haemodialysis n = 35; Continuous 
Ambulatory Peritoneal Dialysis n = 57; Transplant n = 46). 
Results: An 11-item scale was developed from the original 12-item version, with a single factor 
accounting for 59% of the variance and item loadings >0.58. Scale reliability was excellent 
(α=0.93) in the full sample and proved robust to analysis in separate treatment subgroups. As 
expected, RTSQ scores differed significantly (p<0.0001) between transplant and other treatment 
groups. Those who had received a transplant expressed greater overall satisfaction, with specific 
advantages of transplant shown by all individual items including convenience, time, lifestyle, 
freedom and satisfaction to continue current treatment.   
Conclusions: The RTSQ provides a brief, reliable measure of satisfaction with treatment for CKF 
that is suitable for use in routine clinical care and clinical trials. 
 
Keywords: Treatment satisfaction, chronic kidney failure, individual differences 
 
Abbreviations: 
RTSQ: Renal Treatment Satisfaction Questionnaire 
CKF: Chronic Kidney Failure 
CAPD: Continuous Ambulatory Peritoneal Dialysis 
DTSQ: Diabetes Treatment Satisfaction Questionnaire 
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Introduction 
In recent years there has been increasing awareness that excellence in medical care not only 
requires optimal biomedical outcomes but also depends on careful attention to psychological 
outcomes1;2.  Systematic use of questionnaires to measure psychological outcomes has become 
more widespread in clinical trials to evaluate new drugs and other treatment interventions, and in 
routine patient care3. Experience with such measures shows that those designed for specific 
conditions prove more sensitive to individual differences than generic measures, and hence are 
more useful in guiding patient care4;5.  
Despite the invasiveness of treatments for Chronic Kidney Failure (CKF), very few psychological 
measures have been designed specifically for use by patients. Most of the condition-specific 
instruments available (e.g. the Kidney Disease Quality of Life (KDQOL) survey6, the Kidney 
Transplant Questionnaire (KTQ)7) focus on the measurement of health status and mood. However, 
an equally important goal of care is that of patient satisfaction with treatment. Experiences of 
treatment for CKF are likely to vary with the individual, the type of treatment regimen and the 
progression of the disease. Patients may discuss their treatment with healthcare professionals but 
such discussions can be limited by time constraints and conflicting priorities, the difficulty of 
addressing multiple aspects of a treatment regimen, or reluctance (on the part of either patient or 
health professional) to mention sources of dissatisfaction. In these circumstances, it is unlikely 
that a full picture of the individual’s experience will be obtained. Formal measurement of patient 
satisfaction with treatment provides information about the individual patient’s experience that can 
guide the selection and modification of the treatment regimen to suit his/her needs and, thus, is 
central to ensuring the best outcomes for patients. 
The treatments for CKF share many common features with treatments for diabetes, including the 
demands of managing a condition that requires a high commitment to self-care if long-term health 
is to be protected. It is, therefore, appropriate when developing a measure of treatment satisfaction 
specific to the renal condition, to build on experience with treatment satisfaction measures 
designed and developed for use in diabetes. The Diabetes Treatment Satisfaction Questionnaire 
(DTSQ)8;9 has been well validated in many studies, widely used and linguistically validated in 
more than 40 languages10-14. The DTSQ has proved to be a valuable tool in understanding 
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patients’ views of treatment and is sensitive to changes associated with new treatments under 
evaluation in clinical trials15-20. 
The current paper describes the design and initial development of a version of the questionnaire 
specifically for people with CKF: the Renal Treatment Satisfaction Questionnaire (RTSQ). 
  
Methods 
Questionnaire design 
Initial qualitative work to aid the initial drafting of the RTSQ included visits by CB to eight UK 
renal units (Gloucester Royal Hospital, Edinburgh Royal Hospital, Queen Elizabeth Hospital in 
Birmingham, Charing Cross Hospital in London, Leicester General Hospital, Royal Berkshire 
Hospital in Reading, Royal Manchester Infirmary and the Middlesex Hospital in London). In-
depth interviews were carried out by CB with 40 patients at two of the units, Leicester General 
and the Royal Berkshire, as part of a larger study to design measures of quality of life and 
satisfaction and to evaluate an existing measure of well-being for use with people receiving 
treatment for CKF21.  
Interviewees included patients on all forms of dialysis, and those with current or failed 
transplants. During the interviews, patients were asked about sources of satisfaction and 
dissatisfaction with their present treatment and any important ways in which these differ from 
their experience of other forms of renal replacement therapy. Spontaneous mentions of sources of 
satisfaction and dissatisfaction were noted before patients completed draft versions of the RTSQ. 
Six items from the DTSQ appeared to be useful or readily modified to be appropriate for renal 
treatment and interviews confirmed this. Additional items were designed to measure satisfaction 
with other aspects of treatment specific to CKF. Items were designed to be answered by patients 
receiving any form of treatment for CKF, as individual patients may experience a variety of 
treatments throughout the course of their condition. Patients completed early drafts of the RTSQ, 
which were repeatedly extended and modified taking into account the views and experiences of 
interviewees. 
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Survey methods 
The 12-item RTSQ was included in a questionnaire survey of 179 patients receiving renal 
replacement therapy at Leicester General Hospital. The local ethics committee approved the 
survey. Patients received a mailed invitation to participate in the study, together with a 
questionnaire package that included the RTSQ and a general information questionnaire.  They 
were asked to return completed questionnaires to the research team in the pre-paid envelope 
provided.  
Statistical analysis 
Statistical analysis was conducted using SPSS for Windows. The structure of the RTSQ was 
examined using unforced principal components analysis with varimax rotation22. A one-factor 
solution was required to support the summing of individual item scores to form a single Treatment 
Satisfaction score. Cronbach’s alpha reliability analyses were conducted to examine the internal 
consistency of the scale. Descriptive statistics are presented as mean ± standard deviation or         
n (%). Discriminant validity was assessed by investigating differences between treatment groups 
(using Kruskal-Wallis or Mann-Whitney statistics). 
 
Results 
Preliminary version of the RTSQ 
As a result of the initial qualitative interviews, four of the eight items were selected exactly as 
they appeared in the DTSQ and two further items were modified to change the name of the 
condition. A further six items were newly designed to measure other aspects of treatment 
satisfaction of importance to people with CKF.  The instructions ask individuals to rate their 
satisfaction with aspects of treatment over the past few weeks, by circling one number on each of 
the 7-point scales [Figure 1].  
Patient characteristics 
One hundred and forty (78.2%) of the 179 patients accepted the invitation to participate. Of 
the140 participants, 55 (39%) were women. The mean age was 52.8±14.3 years and the mean age 
at leaving full-time education was 16.8±5.4 years. Ninety-eight percent were white European with 
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English as their first language. Seventy-six percent were married or living with a partner, 12% 
were single and 12% were separated, divorced or widowed. 
 
The mean number of years since first renal treatment was 5.6±5.2 years, ranging from 0 to 23 
years. Patients had been receiving their current treatment for a mean of 3.3±3.1 years and had, on 
average, been attending the clinic for 8.0±6.9 years. One quarter of participants had experienced a 
change in their treatment in the past year. Two people did not indicate their current treatment, but 
for the remaining 138 participants, treatment was as follows: Continuous Ambulatory Peritoneal 
Dialysis (CAPD) n=57 (41.3%); Haemodialysis n=35 (25.4%); Transplant n=46 (33.3%). Just 
over half of the participants (52%) reported other comorbid conditions (including diabetes, 
arthritis, hypertension, angina, and other heart conditions) and 26% reported that they were 
registered disabled due to their renal condition. One third of participants had lost workdays over 
the past two months (14.3±21 days, median: 3, range: 0-60).  
 
Structure and reliability 
Investigation of the psychometric properties of the RTSQ using data from all treatment modalities 
revealed a two-factor solution, accounting for 64% of the variance.  A forced one-factor analysis 
resulted in all items loading >0.579 on a single factor, except one (demands), which loaded          -
0.424 and was also the only item to load negatively due to the wording used: How demanding is 
your present method of treatment (in terms of time, effort, thought etc.)? with response options of 
very demanding scored 6 and very undemanding scored 0. The alpha-if-item-deleted statistic for 
the demands item indicated that the reliability of the scale would be improved (from 0.86 to 0.93) 
if this item were removed.    
When the demands item was excluded, unforced principal components analysis of the remaining 
11 items resulted in all items loading >0.58 on a single factor, which accounted for 59% of the 
variance [Table 1]. Reliability of the 11-item RTSQ was excellent (α=0.93) [Table 2] and the 
scale also proved to be robust in analysis of separate treatment groups, for which the coefficient 
alphas ranged between 0.89 and 0.95. The wording of items for the final 11-item scale is shown in 
Figure 2. Investigation of the scale structure in separate treatment subgroups suggests that there 
may be some underlying differences in factor structure between treatment modalities. In the whole 
sample, unforced analysis revealed a one-factor solution. In separate treatment modalities, a 
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forced one-factor solution likewise revealed a single factor with all items loading >0.59.  
However, when an unforced solution was sought separately in each of the three treatment groups, 
items loaded onto two factors (transplant group) or three factors (haemodialysis and CAPD 
groups). 
Scoring 
Reliability analyses indicated that it was possible to remove the 4 best items (convenience, time, 
current, lifestyle) and retain an alpha coefficient >0.86. Removal of a fifth item (flexibility) 
reduced the alpha coefficient to 0.79, which was considered acceptable for a 7-item scale. Thus, 
scales could be calculated using estimated data (i.e. the mean of existing item scores to replace 
missing data) for up to and including 4 missing item scores while maintaining an α of 0.86, and 
for 5 missing scores to maintain an α of 0.79. If ≥7 scores are available, total scores can be 
calculated by summing the item scores, dividing by the count of scores and multiplying by 11. No 
missing values were substituted for the principal components and reliability analyses. For the 
sensitivity to treatment differences analyses (below), up to three missing values were substituted 
with means (no patient had >3 missing scores). 
Discriminant Validity 
Investigation of RTSQ scores by treatment group showed that the RTSQ was sensitive to 
differences in satisfaction with treatment between groups. As expected, total Treatment 
Satisfaction scores differed significantly between treatment groups (χ2 34.97, df=2, p<0.001) 
[Figure 3; Table 3]. Patients who had successful transplants were more satisfied overall than those 
on haemodialysis or CAPD, and were more satisfied with every aspect of their treatment as 
measured by the 11 items.  Although there were no significant differences in total RTSQ scores 
between haemodialysis and CAPD treatment groups, there was a non-significant trend for CAPD-
treated patients to be more satisfied overall (U=675.50; n=30(Haemodialysis) and 56(CAPD); 
p=0.135 ns).  CAPD-treated patients were significantly more satisfied with the amount of 
discomfort or pain associated with their treatment and more likely to recommend their treatment 
to others with CKD [Table 3]. 
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Discussion 
The RTSQ provides an accessible method of obtaining information about patient satisfaction with 
treatment. Item content covers the core aspects of treatment for CKF that were identified by 
patients (during initial interviews) as being central to their experience of satisfaction or 
dissatisfaction. The RTSQ measures key psychological outcomes (such as convenience and 
flexibility) that health professionals are well placed to influence, either by modifying the treatment 
regimen (e.g. by changing the timing of haemodialysis sessions), or by matching treatment 
modality to the individual needs of each patient. Such outcomes are particularly important for 
people with chronic illness, where treatment is necessary for survival but can damage quality of 
life. Studies using the Diabetes Treatment Satisfaction Questionnaire have shown that increasing 
flexibility and convenience can improve the acceptability to patients of intensive treatment 
regimens18;23.    
Psychometric evaluation of the RTSQ demonstrated the internal consistency and factor structure 
of the measure in a combined treatment sample. Due to the relatively small numbers in each 
treatment group (n<60), it was not possible to confirm the stability of the factor structure within 
the separate treatment groups. Larger patient samples are needed to investigate the factor structure 
within treatment subgroups and the possibilities of identifying subscales within the 11 items. 
The failure of one of the 12 items (concerning demands of the treatment) to contribute to the 
single-factor solution was thought to be due more to the item wording than to the construct itself.  
It was the only item in the measure to be worded such that 'more' of the item indicated an 
undesirable outcome.  For all other items 'more' represented a better outcome.  This tendency of 
reversed-wording to detract from scale reliability and structure has been seen in other research 
using different questionnaires24-26, and parallel work developing the HIV-specific Treatment 
Satisfaction Questionnaire27.     
In the current study, the RTSQ was used successfully (78% response rate) in a mailed survey, 
which included several other questionnaires. As the RTSQ is such a brief instrument, it is likely to 
be equally well suited for completion in the renal unit (in paper or computerised format as has 
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been shown for the DTSQ11).  Little is known about those who declined to participate in the 
survey, except that at least one person cited ill-health.  It is unclear how levels of satisfaction 
would be affected if the sample had been complete, but it is probable that non-respondents would 
report less, rather than more, satisfaction with their treatment than respondents.  
The items of the RTSQ were designed to be specific to the treatment of CKF (and of importance 
to patients) while being general enough to be relevant across the treatment groups. For example, 
convenience is an important issue for all patients with CKF, though it will have different meaning 
for patients on each of the three treatment types. The sensitivity of the RTSQ to differences in 
scores between transplant and other treatment groups suggests that the measure is an effective tool 
in assessing patient satisfaction and dissatisfaction with different forms of treatment.  As 
expected, patients on haemodialysis were less satisfied than other groups with the level of 
discomfort/pain associated with their treatment and were least likely to recommend their treatment 
to others with CKD. In the present study, however, no other differences between the CAPD and 
haemodialysis groups reached significance, perhaps due to the small sizes of the treatment 
subgroups.  However, experience with the DTSQ indicates that differences between treatment 
groups are not always apparent (when measured cross-sectionally)28 but become evident when 
measured longitudinally18. Use of the RTSQ in clinical trials will establish the responsiveness of 
the RTSQ to changes in treatment regimens.  
In conclusion, the RTSQ provides a brief, reliable measure of satisfaction with treatment for CKF 
that has preliminary evidence of validity and is suitable for use in routine clinical care and clinical 
trials.  
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Table 1. Unforced single-factor structure for the 11-item RTSQ 
 
Item No. Item content Factor Loading 
 1 Satisfaction with current treatment 0.801 
 2 Satisfaction with control over renal condition 0.682 
 3 Convenience of treatment 0.862 
 4 Flexibility of treatment 0.833 
 5 Satisfaction with freedom afforded by treatment 0.762 
 6 Satisfaction with understanding of condition 0.584 
 7 Satisfaction with time taken by treatment 0.803 
 8 Discomfort or pain involved with treatment 0.786 
 9 How well treatment fits in with lifestyle 0.776 
10 Would you recommend this treatment to others? 0.695 
11 Satisfaction to continue with present treatment 0.796 
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Table 2. Reliability analyses for the 11-item RTSQ (all patients, n=140). 
 
Item no & label 
Scale mean 
if item 
deleted 
Scale 
variance if 
item deleted 
Corrected 
item-total 
correlation 
Square 
multiple 
correlation 
Alpha if item 
deleted 
 1 Current treatment 48.6604 102.7026 .7423 .7188 .9193 
 2 Control        48.6887      107.7783     .6110         .5404         .9250 
 3 Convenience 49.0189 99.2187 .8157 .8263 .9157 
 4 Flexibility 48.9340 101.7194 .7833 .7977 .9175 
 5 Freedom 49.1509 98.8722 .7093 .6409 .9214 
 6 Understand 48.5660 109.1051 .5179 .3472 .9287 
 7 Time 49.1415 99.9512 .7560 .6019 .9185 
 8 Discomfort 48.8491 103.2722 .7270 .6672 .9200 
 9 Lifestyle 49.2264 98.6721 .7260 .7253 .9204 
10 Recommend to       
others  
48.4528 106.0787 .6358 .4909 .9239 
11 Wish to continue  48.4811 102.9568 .7433 .6584 .9194 
Alpha = .9277 (Standardized item alpha = .9279) 
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Table 3. Satisfaction by treatment group 
 
Mean±SD 
Item no & label Haemodialysis 
(n=35) 
CAPD              
(n=57) 
Transplant          
(n=46) 
 1 Current treatment 4.5±1.6 5.1±1.1 5.6±0.8 b, c 
 2 Control        4.7±1.7 5.0±1.1 5.5±0.9 b, d 
 3 Convenience 4.1±1.7 4.6±1.1 5.6±0.8 b, e 
 4 Flexibility 4.3±1.4 4.6±1.3 5.5±0.9 b, e 
 5 Freedom 4.3±1.6 4.3±1.6 5.7±0.9 b, e 
 6 Understand 4.9±1.6 4.3±1.6 5.7±0.9 b, d 
 7 Time 4.3±1.6 4.3±1.3 5.7±0.7 b, e 
 8 Discomfort 4.2±1.5 d 5.0±1.0 a 5.5±0.9 b, c 
 9 Lifestyle 3.7±1.6 4.3±1.5 5.7±0.7 b, e 
10 Recommend to others 4.5±1.7 d 5.4±0.9 a 5.9±0.5 b, e 
11 Wish to continue  4.6±1.6 5.2±1.1 5.8±0.8 b, e 
Treatment Satisfaction 48.5±12.9 52.9±9.2 62.0±6.7 b, e 
 
RTSQ items 1-11 are scored 0-6; maximum score for RTSQ Treatment Satisfaction = 66. 
Significant differences in satisfaction compared with 1) haemodialysis a(p<0.01), b(p<0.001), 2) CAPD c(p<0.05), 
d(p<0.01), e(p<0.001). 
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Legends 
 
Figure 1. Instructions to patients and item format 
Figure 2. Wording (and response anchors) of the 11-item Renal Treatment Satisfaction 
Questionnaire 
Figure 3. Total satisfaction with renal treatment (by treatment type) 
 
 
